2017
DOI: 10.3748/wjg.v23.i40.7292
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal

Abstract: AIMTo determine the prevalence of Epstein-Barr virus (EBV)-associated gastric carcinomas in the North Region of Portugal and to study its clinicopathological characteristics.METHODSWe have performed a retrospective study including a total of 179 consecutive patients with gastric cancer (GC) submitted to gastrectomy during 2011 at the Portuguese Oncology Institute of Porto. Clinical and pathological data was collected from individual clinical records and inserted on a database with unique codification. Tumour t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
17
2
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(23 citation statements)
references
References 45 publications
3
17
2
1
Order By: Relevance
“…It has been well recognized that the occurrence of GCLS is associated with EBV in most cases. Although only limited cases of ASC associated with EBV have been reported (5), the SCC components of the two previously reported cases and the present case were not associated with EBV infection. Therefore, additional studies are needed to clarify the clinicopathological features and pathogenesis of gastric ASC, including the association with GCLS.…”
Section: Discussioncontrasting
confidence: 41%
“…It has been well recognized that the occurrence of GCLS is associated with EBV in most cases. Although only limited cases of ASC associated with EBV have been reported (5), the SCC components of the two previously reported cases and the present case were not associated with EBV infection. Therefore, additional studies are needed to clarify the clinicopathological features and pathogenesis of gastric ASC, including the association with GCLS.…”
Section: Discussioncontrasting
confidence: 41%
“…[7,16] Several studies in Asia, Europe, and America reveal the prevalence close to 9% for EBV-associated early and advanced gastric carcinomas. [16,[19][20][21] In our present study, the frequency of EBV infection in gastric carcinoma with lymphoid stroma (72.7%, 8/11) is in agreement with that of previous studies. [5-7, 10, 22] The prevalence of EBV infection in conventional early gastric carcinoma in our study (1.8%, 2/109) was lower than that previously reported.…”
Section: Prognosissupporting
confidence: 93%
“…[5-7, 10, 22] The prevalence of EBV infection in conventional early gastric carcinoma in our study (1.8%, 2/109) was lower than that previously reported. [20] The discrepancy may be related to the exclusion of gastric stump carcinoma and synchronous gastric carcinoma in our cohort, because up to 35% gastric stump carcinomas showed EBV infection and EBV-associated gastric carcinoma often have multiple synchronous gastric carcinomas. [19,23,24] As illustrated in the present study, EBV-GCLS demonstrated histopathologic patterns characterized by a pushing tumor invasion front, dense intra-tumoral lymphocytic in ltration, poor tumor cell differentiation, high nuclear grade, and sheet, cluster, or nest growth patterns, as described previously.…”
Section: Prognosismentioning
confidence: 74%
“…The gold standard technique for the detection of EBV in tissues is ISH with EBV EBERs (EBER-ISH) due to its high sensitivity and specificity to determine the precise intranuclear localization of the EBVinfected cells. The diagnosis of EBV-associated gastric cancer is confirmed by the presence of EBER within the tumor cells and its absence in the normal tissue adjacent to the tumor [3]. Many studies have reported the higher prevalence of EBV among gastric cancer patients by PCR assay than EBER-ISH technique [83].…”
Section: Discussionmentioning
confidence: 99%